SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000905718-18-001016
Filing Date
2018-12-31
Accepted
2018-12-31 16:38:54
Documents
1
Group Members
PARK WEST INVESTORS MASTER FUND, LTDPETER S. PARK

Document Format Files

Seq Description Document Type Size
1 PLX PHARMA INC. AMENDMENT NO. 1 plxpharma_13dam1dec202018.htm SC 13D/A 97998
  Complete submission text file 0000905718-18-001016.txt   99804
Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939 (415) 524-2902
Park West Asset Management LLC (Filed by) CIK: 0001386928 (see all company filings)

IRS No.: 300132084 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88072 | Film No.: 181260132
SIC: 2834 Pharmaceutical Preparations